MedTrace Logo

A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening

NCT07032961 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2025-07-04

No results posted yet for this study

Summary

The goal of this is to learn about the effectiveness and feasibility of a novel AI- assisted Mobile Capsule Gastroscopy (MCG) system for detecting gastric pathologies in elderly and high-risk populations.

The main question it aims to answer is:

Can MCG effectively detect gastric pathologies, including common gastric diseases, gastric cancer, and precancerous lesions, in elderly and high-risk individuals at community health centers?

Participants will:

Epidemiological, diagnostic, and post-MCG follow-up data generated during participants' involvement in the gastric pathologies public screening program will be collected.

Conditions

  • Gastritis
  • Gastric Dysplasia
  • Gastric Ulcer
  • Gastric Cancer
  • Gastric Mass

Interventions

OTHER

Collect epidemiological, diagnostic, and follow-up data after MCG examination.

MCG System: GICE-1000 Manufacturer: Guangzhou Side Medical Technology Co., Ltd.

Sponsors & Collaborators

  • Guangzhou First People's Hospital

    collaborator OTHER

  • Second Affiliated Hospital of Guangzhou Medical University

    collaborator OTHER

  • Guangdong Provincial Hospital of Traditional Chinese Medicine

    collaborator OTHER

  • Nanfang Hospital, Southern Medical University

    lead OTHER

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-24
Primary Completion
2026-10-31
Completion
2030-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07032961 on ClinicalTrials.gov